Innovations in Pharmaceutical Microbiology
London, UK (PRWEB UK) 19 September 2014 -- SMi Group are thrilled to announce that registration is now open to attend the 4th annual conference, Pharmaceutical Microbiology , taking place on 21st & 22nd January in Central London.
Innovations can be found in all areas of pharmaceutical microbiology but best practice, strategy and efficiency has become a necessity in order to excel in the prevention, detection and management of microorganisms.
Pharmaceutical Microbiology 2015 will ask the questions: What are the best approaches in contamination control? Where does microbiological risk assessment interact with HACCP? How do we develop and manage the sterilisation and validation process? When can we use a scoring system to avoid unnecessary microbiological testing? What are the latest approaches to preventing biofilms?
Attendees will hear case study driven presentations from an array of market leaders such as GSK, Genzyme, Abbott, MedImmune and AstraZeneca, discussing the benefits and challenges of rapid methods, risk assessments, objectionable organisms, plus much more.
Oliver Chancel, Sterility and Aspeptic Process Assurance Expert from Merial Sas, who will be chairing the event said:
“I have attended the last 2 Microbiology conference and have appreciated that outstanding experts from the pharmaceutical industry, and international academia presented various microbiological aspects with a series of case studies to focus on the practical knowledge and the “know how” which can be directly applied on daily business. I look forward to attending the new conference in London as it is likely to provide an incredible forum for open discussions with speakers and attendants.”
Key Speakers for the 4th annual show will include:
• Olivier Chancel, Sterility and Aseptic Process Assurance Expert, Merial Sas – CONFERENCE CHAIRMAN
• Ruth Daniels, Head of MSAT, Microbiology, Genzyme
• Sara Gamberini, Molecular Biology Scientist, Merck Serono
• Hans Noordergraaf, Microbiologist, Abbott Biologicals
• Thomas Schwartz, Microbiology & Molecular Biology Group Leader, Forschungszentrum Karlsrube Gmbh
• Tim Eaton, Sterile Manufacturing, Specialist, AstraZeneca
• Stephen Rawling, Microbiology Team Leader, GlaxoSmithKline
• Phil Duncanson, Director of QC, MedImmune
For those who are interested in registering there is currently a £300 early bird discount available which expires on 30th September.
For further details or to secure a place visit http://www.pharma-microbiology.com
Pharmaceutical Microbiology
21-22 January 2015
Marriott Regents Park Hotel, London UK
http://www.pharma-microbiology.com
END
About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries.
We pride ourselves on having access to the worlds most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk
Sonal Patel, SMi Group Ltd, http://www.smi-online.co.uk/2014military-airlift2.asp, +44 2078276088, [email protected]
Share this article